top of page
Contact Us
Contact Us

More case studies

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

How the flexibility and initiative of CSI’s Quality team overcame challenges to ensure timely product supply for a partner’s ongoing clinical trial

A Quality Solution to Clinical Trial Supply

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets

Oncology Product Batch Hunting

How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a single product were supplied on time to multiple countries

Delivering Comparators for a Global Allergy Study

How CSI’s regulatory guidance and robust sourcing solutions ensured the success of a global flu vaccine trial that could not afford to run behind schedule

Sourcing Flu Vaccines for a Global Trial

How CSI leveraged its vendor and warehouse networks to supply aflibercept for a leading CRO’s study within a tight deadline

Rapid Eylea Study Supply

How CSI’s scientific insight delivered an agile sourcing model and substantial cost savings for a listed biotechnology company’s global trial

Streamlining Biotechnology Supply Chains

Request

A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a Phase II ophthalmology clinical trial. The study required precise planning and timely execution to ensure uninterrupted supply across multiple global sites. The client prioritised batch consistency and Certificates of Analysis (CoA) for all supplies.

Challenge

The biotech client faced several hurdles in sourcing Lucentis for their study:


Lucentis, being a high-demand ophthalmology drug, had limited availability in the required markets. Additionally, the client required detailed Certificates of Analysis (CoA) for each batch to ensure quality and to ensure that the sourced drug met regulatory requirements across different countries.


To make matters more complex, the client required a single batch to maintain uniformity across batches to avoid variability in trial results. The study had stringent timelines, leaving no room for delays in procurement or delivery.

Solution

CSI leveraged its expertise and global network to address the client’s needs. Utilizing CSI’s established relationships with manufacturers and distributors, the team secured sufficient quantities of Lucentis, considering multiple purchases throughout the study according to the shelf life of the product.


The sourcing strategy also focused on regions with regulatory alignment to the study’s requirements and through careful planning, CSI sourced Lucentis from the same production lots whenever possible, ensuring batch-to-batch consistency.

Case Study

Comparator Sourcing for a Phase II Ophthalmology Study

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Request

The clinical trial proceeded without delays and the client acknowledged CSI’s contribution as instrumental in meeting their ambitious timelines

Challenge

Limited availability of high-demand drug Lucentis, need for batch consistency,
regulatory compliance, and strict timelines.

Solution

CSI leveraged its global network to secure Lucentis, prioritized regulatory-aligned sourcing, ensured batch consistency, and optimized logistics for timely delivery.

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

Contact us 

bottom of page